Accelmed, Peregrine Ventures pump up NLT Spine's funding to $14.5M

Back problems are common afflictions, and many people require surgery to alleviate their suffering. One Israeli company has just received a cash infusion to advance its line of minimally invasive products and make a bigger splash on the U.S. market.

NLT Spine is developing minimally invasive spine surgery products. It has already aroused the interest of Accelmed and Peregrine Ventures, which have driven up the company's funding to $14.5 million as it looks to expand its presence in the U.S.

Minimally invasive spinal surgery is becoming evermore popular, as people seek to experience less postoperative discomfort. NLT is looking to capitalize on this trend.

NLT's products are based on its non-linear core technology, which allows the insertion of large implants and instruments through a small incision. It plans to officially launch its PROW LIF line and additional products next year. It already has experienced some success in the U.S.: The PROW Fusion has recently received 510(k) clearance and is available under limited release.

- get the NLT release

Suggested Articles

Boehringer Ingelheim tapped Healx to help identify new drug indications and leverage its AI to explore R&D options in neurological diseases.

CMR Surgical will have a new CEO at the top of the year, as it kicks off the global launch of its modular Versius system while awaiting FDA approval.

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.